Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 10124-2-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#10124-2-AP, RRID:AB_2218174
- Product name
- VGLL1 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated VGLL1 antibody (Cat. #10124-2-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC, WB, ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references N(6)-methyladenosine-modified VGLL1 promotes ovarian cancer metastasis through high-mobility group AT-hook 1/Wnt/β-catenin signaling.
A novel signature constructed by mitochondrial function and cell death-related gene for the prediction of prognosis in bladder cancer.
TNF-α Secreted from Macrophages Increases the Expression of Prometastatic Integrin αV in Gastric Cancer.
PI3K/AKT/β-Catenin Signaling Regulates Vestigial-Like 1 Which Predicts Poor Prognosis and Enhances Malignant Phenotype in Gastric Cancer.
VGLL1 expression is associated with a triple-negative basal-like phenotype in breast cancer.
Li H, Cai L, Pan Q, Jiang X, Zhao J, Xiang T, Tang Y, Wang Q, He J, Weng D, Zhang Y, Liu Z, Xia J
iScience 2024 Mar 15;27(3):109245
iScience 2024 Mar 15;27(3):109245
A novel signature constructed by mitochondrial function and cell death-related gene for the prediction of prognosis in bladder cancer.
Yan Z, Liu Y, Wang M, Wang L, Chen Z, Liu X
Scientific reports 2024 Jun 25;14(1):14667
Scientific reports 2024 Jun 25;14(1):14667
TNF-α Secreted from Macrophages Increases the Expression of Prometastatic Integrin αV in Gastric Cancer.
Hwang MA, Won M, Im JY, Kang MJ, Kweon DH, Kim BK
International journal of molecular sciences 2022 Dec 26;24(1)
International journal of molecular sciences 2022 Dec 26;24(1)
PI3K/AKT/β-Catenin Signaling Regulates Vestigial-Like 1 Which Predicts Poor Prognosis and Enhances Malignant Phenotype in Gastric Cancer.
Kim BK, Cheong JH, Im JY, Ban HS, Kim SK, Kang MJ, Lee J, Kim SY, Park KC, Paik S, Won M
Cancers 2019 Dec 3;11(12)
Cancers 2019 Dec 3;11(12)
VGLL1 expression is associated with a triple-negative basal-like phenotype in breast cancer.
Castilla MÁ, López-García MÁ, Atienza MR, Rosa-Rosa JM, Díaz-Martín J, Pecero ML, Vieites B, Romero-Pérez L, Benítez J, Calcabrini A, Palacios J
Endocrine-related cancer 2014 Aug;21(4):587-99
Endocrine-related cancer 2014 Aug;21(4):587-99
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Jurkat cells were subjected to SDS PAGE followed by western blot with 10124-2-AP(VGLL1 antibody) at dilution of 1:1000
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The VGLL1 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human VGLL1. This antibody recognizes human antigen. The VGLL1 antibody has been validated for the following applications: ELISA, IHC, WB analysis.